Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187174 | SCV000240754 | likely benign | not specified | 2018-03-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000187174 | SCV000247051 | uncertain significance | not specified | 2015-08-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000227817 | SCV000289924 | likely benign | Cortical dysplasia-focal epilepsy syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000515191 | SCV000611461 | uncertain significance | Autism, susceptibility to, 15; Cortical dysplasia-focal epilepsy syndrome | 2017-05-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314708 | SCV000849284 | likely benign | Inborn genetic diseases | 2022-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000187174 | SCV000856758 | likely benign | not specified | 2017-09-28 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000515191 | SCV000898622 | uncertain significance | Autism, susceptibility to, 15; Cortical dysplasia-focal epilepsy syndrome | 2021-11-11 | criteria provided, single submitter | clinical testing | CNTNAP2 NM_014141 exon 8 p.Ser382Asn (c.1145G>A): This variant has not been reported in the literature but is is present in 0.7% (220/34350) of Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs371839994). This variant is present in ClinVar (Variation ID:205233). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Mayo Clinic Laboratories, |
RCV003480545 | SCV004224120 | uncertain significance | not provided | 2022-07-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955123 | SCV004768526 | likely benign | CNTNAP2-related condition | 2024-02-26 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |